new glp 1 agonist GLP-1 agonists approved for clinical use. GLP-1 agonists are available This is a blog that
Description
However, it was not derived from patient focus groups nor was it initially designed to quantify pain, which has limited its application in some settings
2022 JAMA Internal Medicine meta-analysis: pooling 76 randomised controlled trials, GLP-1 receptor agonist use was associated with a relative risk of 1.37 for biliary disease compared with placebo or other treatments
doi:10.1002/oby.20340 56
doi: 10.1016/j.cmet.2018.03.001 [DOI] [PubMed] [Google Scholar] 2.Holt MK, Richards JE, Cook DR, et al
